2m 2m 2m 2m 2m 2m 2m
CELCUITY (CELC)
NASDAQ
$86.83+$0.45 (+0.52%)
Price as of Jul 31, 2026 7:34 PM EDT- $4.2BMarket Cap
- 116.44%1-Year Change
- BiotechnologyIndustry
CELCUITY (CELC)
$86.83+$0.45 (+0.52%)
CELC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $86.38 | ||
Change | -$1.26 (-1.44%) | ||
Open | $88.50 | ||
High | $88.50 | ||
Low | $85.46 | ||
Previous Close | $87.64 | ||
Volume | 677,931 | ||
30-Day Average Volume | 1,771,986 | ||
1-Week Change | 4.55% | ||
1-Month Change | -17.43% | ||
1-Year Change | 116.44% | ||
3-Year Change | 774.29% | ||
5-Year Change | 338.48% | ||
Fundamentals | |||
Shares Outstanding | 48.8M | ||
Total Assets | $410.2M | ||
Market Cap | $4.2B | ||
Enterprise Value | $4.4B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$55.3M | ||
EBIT | $1.6M | ||
EBITDA | $1.6M | ||
Net Working Capital | $375.7M | ||
EPS | -$0.97 | ||
Enterprise Value/EBITDA | 2,666 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -89 | ||
PEG | N/A | ||
Price/Free Cash Flow | -76 | ||
Price/Operating Cash Flow | -76 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue